» Articles » PMID: 36546557

Genome-wide Association Analysis Identifies a Susceptibility Locus for Sporadic Vestibular Schwannoma at 9p21

Abstract

Vestibular schwannomas are benign nerve sheath tumours that arise on the vestibulocochlear nerves. Vestibular schwannomas are known to occur in the context of tumour predisposition syndromes NF2-related and LZTR1-related schwannomatosis. However, the majority of vestibular schwannomas present sporadically without identification of germline pathogenic variants. To identify novel genetic associations with risk of vestibular schwannoma development, we conducted a genome-wide association study in a cohort of 911 sporadic vestibular schwannoma cases collated from the neurofibromatosis type 2 genetic testing service in the north-west of England, UK and 5500 control samples from the UK Biobank resource. One risk locus reached genome-wide significance in our association analysis (9p21.3, rs1556516, P = 1.47 × 10-13, odds ratio = 0.67, allele frequency = 0.52). 9p21.3 is a genome-wide association study association hotspot, and a number of genes are localized to this region, notably CDKN2B-AS1 and CDKN2A/B, also referred to as the INK4 locus. Dysregulation of gene products within the INK4 locus have been associated with multiple pathologies and the genes in this region have been observed to directly impact the expression of one another. Recurrent associations of the INK4 locus with components of well-described oncogenic pathways provides compelling evidence that the 9p21.3 region is truly associated with risk of vestibular schwannoma tumorigenesis.

Citing Articles

Current molecular understanding of central nervous system schwannomas.

Tsuchiya T, Miyawaki S, Teranishi Y, Ohara K, Hirano Y, Ogawa S Acta Neuropathol Commun. 2025; 13(1):24.

PMID: 39910685 PMC: 11796276. DOI: 10.1186/s40478-025-01937-w.


Deciphering the causal landscape: genetic insights into sporadic vestibular schwannoma risk factors through Mendelian Randomization.

Liu Y, Feng H, Ma H, Li J, Yu Y, Zhao H Discov Oncol. 2024; 15(1):737.

PMID: 39621164 PMC: 11612107. DOI: 10.1007/s12672-024-01644-3.


Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential.

Hussain M, Sharma S, Kumari A, Kamran A, Bahl G, Bisht A Epigenomics. 2024; 16(23-24):1453-1464.

PMID: 39601046 PMC: 11622780. DOI: 10.1080/17501911.2024.2430170.


Assessing causal associations between neurodegenerative diseases and neurological tumors with biological aging: a bidirectional Mendelian randomization study.

Zhang Z, Liu N, Pan X, Zhang C, Yang Y, Li X Front Neurosci. 2024; 17:1321246.

PMID: 38169680 PMC: 10758410. DOI: 10.3389/fnins.2023.1321246.

References
1.
Hadfield K, Smith M, Urquhart J, Wallace A, Bowers N, King A . Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene. 2010; 29(47):6216-21. DOI: 10.1038/onc.2010.363. View

2.
Topalidou I, Cattin-Ortola J, Hummer B, Asensio C, Ailion M . EIPR1 controls dense-core vesicle cargo retention and EARP complex localization in insulin-secreting cells. Mol Biol Cell. 2019; 31(1):59-79. PMC: 6938272. DOI: 10.1091/mbc.E18-07-0469. View

3.
Kumar R, Smeds J, Lundh Rozell B, Hemminki K . Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas. Melanoma Res. 1999; 9(2):138-47. DOI: 10.1097/00008390-199904000-00005. View

4.
Kshettry V, Hsieh J, Ostrom Q, Kruchko C, Barnholtz-Sloan J . Incidence of vestibular schwannomas in the United States. J Neurooncol. 2015; 124(2):223-8. DOI: 10.1007/s11060-015-1827-9. View

5.
Evans D, Wallace A, Hartley C, Freeman S, Lloyd S, Thomas O . Familial unilateral vestibular schwannoma is rarely caused by inherited variants in the NF2 gene. Laryngoscope. 2018; 129(4):967-973. PMC: 6563429. DOI: 10.1002/lary.27554. View